Eugia US LLC — Class III: Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only
Eugia US LLC has initiated a Class III recall for specific lots of Lidocaine HCl Injection, USP 2%, because the label wrap covers the barcode, rendering it difficult to scan.
This affects Eugia US LLC, healthcare providers utilizing Lidocaine HCl 2% single-dose vials, and pharmaceutical labeling and packaging departments.
While a Class III recall indicates the product is unlikely to cause adverse health consequences, barcode scannability issues can disrupt hospital workflows and pharmacy inventory management. This suggests a localized failure in the labeling application or design process that failed to account for barcode clearance.
Review labeling application processes for vial wraps to ensure barcode visibility is maintained; verify that secondary packaging or label placement does not interfere with scannability during QA inspections.
Class III. Reason: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan. Product: Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02. Firm: Eugia US LLC (East Windsor NJ United States). Status: Ongoing.
Open in openFDA / FDA.gov